Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
16 Nov 2022, 07:00
4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology &…
10 Nov 2022, 14:00
4D pharma today presented new biomarker data from two ongoing clinical trials of its lead…
5 Oct 2022, 13:00
4D pharma plc (AIM: DDDD) today announces two poster presentations at the Society for Immunotherapy…
24 Aug 2022, 07:00
4D pharma announces the publication of pre-clinical research relating to its live biotherapeutic…
26 May 2022, 17:30
4D pharma today announced the presentation of a trial in progress poster from the Phase II clinical…
17 May 2022, 07:00
4D pharma announces the presentation of a late-breaking poster on data from Part A of the Phase I/II…
23 Mar 2022, 07:00
Primary Efficacy Endpoint Met Early in Renal Cell Carcinoma Group in Part B of Study. Company to…
22 Feb 2022, 07:00
4D pharma today announces US FDA clearance of its IND applications for Live Biotherapeutics MRx0005…
27 Jan 2022, 07:00
Part A of the Phase I/II clinical trial achieved the primary endpoint of safety and tolerability.…
3 Jan 2022, 12:00
4D pharma plc announces the appointment of John Doyle as Chief Financial Officer (CFO). Mr. Doyle…
13 Dec 2021, 07:00
Part A of the study meets primary endpoint of safety and tolerability
MRx-4DP0004 also achieved…
9 Dec 2021, 07:00
Results demonstrate changes in gut microbiome structure following administration of Blautix in both…
2 Aug 2021, 07:00
4D pharma announces two poster presentations at the European Society for Medical Oncology (ESMO)…
29 Jul 2021, 07:00
4D pharma announces the closing of a senior secured credit facility for up to $30m with Oxford…
